Blog Category

Press Releases

Biophytis-LynxKite Alliance Expands to Turbocharge AI-driven drug discovery for next generation longevity therapeutics

,

/

12 March 2026

Biophytis announces completion of over €2.0 million capital increase and the repayment of all variable price convertible debt

,

/

11 March 2026

Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund

,

/

28 February 2026

Biophytis enters strategic agreement in Asia and secures $20 million for launch of Phase 3 trial in sarcopenia

, ,

/

28 January 2026

Biophytis to Participate in the JP Morgan Healthcare Conference and the Biomed Forum

,

/

12 January 2026

Results of the Combined General Meeting of November 13, 2025

/

13 November 2025

Biophytis Reports First-Half 2025 Results and Provides Strategic Update

, , , ,

/

30 October 2025

BIOPHYTIS and a Consortium of Investors including RONGHUI RENHE Life Technology Join Forces to Finance and Launch First-Ever Phase 3 Trial in Sarcopenia

,

/

13 October 2025

Biophytis to Participate in Four Key Events in Q4 2025

,

/

30 September 2025

Biophytis Secures public funding in Brazil for Obesity Phase 2 Trial and Signs Agreements with Leading local Clinical Partners

,

/

15 September 2025

Biophytis unveils Phase 3 Sarcopenia Trial Strategy with BIO101 in Europe and Asia

,

/

11 September 2025

Biophytis obtains EMA authorization to launch its Phase 2 clinical trial in obesity

,

/

3 September 2025